Filing Details

Accession Number:
0001209191-20-057311
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-06 17:08:44
Reporting Period:
2020-11-05
Accepted Time:
2020-11-06 17:08:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1382101 Sutro Biopharma Inc. STRO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1326592 Trevor Hallam C/O Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco CA 94080
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-05 16,751 $4.36 53,463 No 4 M Direct
Common Stock Disposition 2020-11-05 16,751 $15.00 36,712 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2020-11-05 16,751 $0.00 16,751 $4.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,183 2021-02-08 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder.
  2. The option is fully vested and exercisable.